Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emerging Biopharma
Research
Fatty acid eye injections restore vision in old mice
Lucina Biotherapeutics, a company co-founded by the study's leader, is now formulating the molecule for IND-enabling studies.
Darren Incorvaia
Sep 26, 2025 2:10pm
Eli Lilly opens latest incubator site in San Diego
Sep 26, 2025 9:55am
New York Stock Exchange honors Fierce 15 winners
Sep 23, 2025 10:16am
Fierce Biotech's 2025 Fierce 15
Sep 22, 2025 8:00am
US VC launches another biotech with China-licensed asset
Sep 17, 2025 10:30am
Pfizer vet takes CEO post at new, phase 3-ready biotech
Sep 9, 2025 10:03am
More News
Corsera launches with $50M for predictive AI tool, RNAi asset
Sep 2, 2025 6:30am
RNA biotech emerges with $52M and clinical rare disease asset
Aug 25, 2025 10:13am
Is Basel the next Boston? The Swiss biotech hub raising its game
Aug 8, 2025 9:50am
Charles River explores crowdfunding for cell and gene incubator
Aug 4, 2025 2:55pm
See more stories